Ordeniza, Juncris P.
HRN: 20-79-98 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2024
CEFTRIAXONE 1G (VIAL)
01/01/2024
01/07/2024
IV
700mg
OD
T/c Septic Shock
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes